4//SEC Filing
BROWN MORGAN R 4
Accession 0001562180-24-004945
CIK 0001822791other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:23 PM ET
Size
8.5 KB
Accession
0001562180-24-004945
Insider Transaction Report
Form 4
Clene Inc.CLNN
BROWN MORGAN R
Chief Financial Officer
Transactions
- Award
Stock Options (Right to buy)
2024-06-07+400,000→ 400,000 totalExercise: $0.37Exp: 2034-06-06→ Common Stock (400,000 underlying) - Award
Stock Options (Right to buy)
2024-06-07+600,000→ 600,000 totalExercise: $0.37Exp: 2034-06-06→ Common Stock (600,000 underlying)
Footnotes (2)
- [F1]This option was granted on June 7, 2024 as an option for 400,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested
- [F2]This option was granted on June 7, 2024 as an option for 600,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs.
Documents
Issuer
Clene Inc.
CIK 0001822791
Entity typeother
Related Parties
1- filerCIK 0001266062
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:23 PM ET
- Size
- 8.5 KB